½ÃÀ庸°í¼­
»óǰÄÚµå
1392252

¼¼°èÀÇ °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global Large Molecule Bioanalytical Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 179 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2022³â 85¾ï 6,000¸¸ ´Þ·¯¿¡¼­ 2030³â 204¾ï 9,000¸¸ ´Þ·¯¿¡ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â Á¶»ç ±â°£ µ¿¾È 11.53%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú¿¡´Â ½ÇÁúÀûÀÎ »ý¹°ÇÐÀû ºÐÀÚÀÇ ºÐ¼® ¹× Ư¼º ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ ¹æ¹ý°ú ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ºÐÀÚ¿¡´Â ´Ü¹éÁú, ÆéŸÀ̵å, Ç×ü, ÇÙ»ê ¹× ±âŸ °íºÐÀÚ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â¼úÀº ¹ÙÀÌ¿ÀÀǾàǰ, »ý¸í°øÇÐ ¹× »ý¸í°úÇÐ ºÐ¾ß¿¡¼­ ÀǾàǰ °³¹ß, ¿¬±¸ ¹× Ä¡·á ÀÀ¿ë¿¡ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

´Ü¹éÁú, Ç×ü, ÇÙ»ê ±â¹Ý ÀǾàǰÀ» Æ÷ÇÔÇÑ ¹ÙÀÌ¿ÀÀǾàǰ ¹× º¹ÇÕ Ä¡·áÁ¦¿¡ ´ëÇÑ °ü½ÉÀº ÀǾàǰ °³¹ß °úÁ¤¿¡¼­ ÀÌ·¯ÇÑ °íºÐÀÚ¸¦ ºÐ¼®ÇÏ°í Æ¯¼ºÈ­ÇÏ´Â ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¿¬±¸, ƯÈ÷ Áúº´À» ÀÌÇØÇϰí Ç¥Àû Ä¡·á¹ýÀ» °³¹ßÇϱâ À§ÇÑ Á¶»çÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ ºÐÀÚ¸¦ ¿¬±¸Çϱâ À§ÇÑ °í±Þ ºÐ¼® µµ±¸¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á·ÎÀÇ ÀüȯÀº ¸ÂÃãÇü Ä¡·á¸¦ Áö¿øÇÏ´Â Á¤¹Ð ¹ÙÀÌ¿À ºÐ¼® ±â¼úÀÇ Çʿ伺À» ´õ¿í °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀǾàǰÀÇ ¾ÈÀü¼º, À¯È¿¼º ¹× ǰÁúÀÇ Àϰü¼ºÀ» º¸ÀåÇÏ´Â °ÍÀº ƯÈ÷ ±ÔÁ¦ ´ç±¹ÀÌ °íºÐÀÚ Æ¯¼º ºÐ¼®¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» Á¦½ÃÇÔ¿¡ µû¶ó °­·ÂÇÑ ¹ÙÀÌ¿À ºÐ¼® µµ±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãŵ´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü, ¾÷°è¿ÍÀÇ Çù·Â, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¹ÙÀÌ¿ÀÀǾàǰ È®´ë´Â ½ÃÀå ¼ºÀå¿¡ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» Á¾ÇÕÇØ º¼ ¶§, ÷´Ü ¹ÙÀÌ¿À ºÐ¼® ±â¼úÀÌ Çõ½ÅÀ» ÃËÁøÇϰí, ±ÔÁ¦ ±âÁØÀ» ÃæÁ·Çϸç, ¹ÙÀÌ¿ÀÀǾàǰ ¹× ¸ÂÃãÇü Ä¡·á¹ý °³¹ßÀ» ÃËÁøÇÏ´Â µ¥ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ½À» ¾Ë ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ªº° ºÐ¼®:

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù. ÀúÈñ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

  • Á¦Ç° ¹× ¼­ºñ½ºº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç° ¹× ¼­ºñ½ºº° ºÐ¼®
  • Á¦Ç°(¼Ò¸ðǰ¡¤¾×¼¼¼­¸®, Àåºñ, ½Ã¾à¡¤Å°Æ®)
  • ¼­ºñ½º

Á¦6Àå °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • »ý¹°Á¦Á¦
  • ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå À¯·¡ ÀǾàǰ¡¤ºÐÀÚ
  • ¹ÙÀÌ·¯½º º¤ÅÍ
  • ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á
  • ³ª³ëÀÔÀÚ¡¤Æú¸®¸Ó

Á¦7Àå °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ±â¾÷ °æÀï »óȲ

  • °íºÐÀÚ ¹ÙÀÌ¿À ºÐ¼® ±â¼ú ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇùÁ¤
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Intertek Group plc
  • Solvias AG
  • Bio-Techne Corporation
  • Wyatt Technology Corporation
  • Precision NanoSystems
  • Verder
  • Halo Labs
  • Charles River Laboratories International Inc.
  • Avomeen
  • Merck KGaA
  • Cergentis B.V.
  • Laboratory Corporation of America Holdings
  • SCIEX
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories Inc.
ksm 23.12.20

The global demand for Large Molecule Bioanalytical Technologies Market is presumed to reach the market size of nearly USD 20.49 BN by 2030 from USD 8.56 BN in 2022 with a CAGR of 11.53% under the study period 2023 - 2030.

Bioanalytical technologies for large molecules involve a variety of methods and techniques employed for the analysis and characterization of substantial biological molecules. These molecules include proteins, peptides, antibodies, nucleic acids, and other macromolecules. These technologies are vital in the fields of biopharmaceuticals, biotechnology, and life sciences for drug development, research, and therapeutic applications.

MARKET DYNAMICS:

The focus on biopharmaceuticals and complex therapeutics, including proteins, antibodies, and nucleic acid-based drugs, fuels the demand for technologies that analyze and characterize these large molecules during drug development. Advancements in life sciences research, particularly in understanding diseases and developing targeted therapies, necessitate sophisticated analytical tools for studying these molecules. The shift towards personalized medicine further accentuates the need for precise bioanalytical technologies to support customized therapies. Ensuring drug safety, efficacy, and quality consistency drives the demand for robust bioanalytical tools, especially as regulatory agencies enforce stringent guidelines for large molecule characterization. Continuous technological advancements, industry collaborations, and the expansion of biopharmaceuticals in emerging markets contribute significantly to the market's growth. Altogether, these factors underscore the importance of advanced bioanalytical technologies in driving innovation, meeting regulatory standards, and advancing the development of biopharmaceuticals and personalized therapies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of large molecule bioanalytical technologies. The growth and trends of large molecule bioanalytical technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the large molecule bioanalytical technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

  • Products (Consumables & Accessories, Instruments, Reagents & Kits)
  • Services

By Application

  • Biologics
  • Oligonucleotide Derived Drugs & Molecules
  • Viral Vector
  • Cell & Gene Therapy
  • Nanoparticles & Polymers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Large Molecule Bioanalytical Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Large Molecule Bioanalytical Technologies market include Intertek Group plc, Solvias AG, Bio-Techne Corporation, Wyatt Technology Corporation, Precision NanoSystems, Verder, Halo Labs, Charles River Laboratories International, Inc., Avomeen, Merck KGaA, Cergentis B.V., Laboratory Corporation of America Holdings, SCIEX, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Services
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES MARKET ANALYSIS BY PRODUCT & SERVICES

  • 5.1 Overview by Product & Services
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Services
  • 5.4 Products (Consumables & Accessories, Instruments, Reagents & Kits) Historic and Forecast Sales by Regions
  • 5.5 Services Historic and Forecast Sales by Regions

6 . GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Biologics Historic and Forecast Sales by Regions
  • 6.5 Oligonucleotide Derived Drugs & Molecules Historic and Forecast Sales by Regions
  • 6.6 Viral Vector Historic and Forecast Sales by Regions
  • 6.7 Cell & Gene Therapy Historic and Forecast Sales by Regions
  • 6.8 Nanoparticles & Polymers Historic and Forecast Sales by Regions

7 . GLOBAL LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES COMPANIES

  • 8.1. Large Molecule Bioanalytical Technologies Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF LARGE MOLECULE BIOANALYTICAL TECHNOLOGIES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Intertek Group plc
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Solvias AG
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Bio-Techne Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Wyatt Technology Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Precision NanoSystems
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Verder
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Halo Labs
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Charles River Laboratories International Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Avomeen
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Merck KGaA
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Cergentis B.V.
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Laboratory Corporation of America Holdings
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. SCIEX
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. F. Hoffmann-La Roche AG
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Bio-Rad Laboratories Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦